Hester Biosciences Ltd

Hester Biosciences Ltd | Sector: Pharmaceuticals | ISIN: INE782E01017

₹ 1,567.20 (-4.06%)

29 Mar, 2023, 3:56:18 PM

Trade

Open
₹ 1,604.10

Prev. Close
₹ 1,633.45

Turnover(lac)
₹ 160.58

Day's High
₹ 1,626.20

Day's Low
₹ 1,546.00

52 Wk High
₹ 2,949.60

52 Wk Low
₹ 1,404.55

Book Value
₹ 346.21

Face Value
₹ 10.00

Mkt. Cap (Cr.)
₹ 1,333.20

P/E
43.31

EPS
36.47

Div. Yield
0.63

Stock View

HOLD

Target | 06 Feb, 2023

1,830 (16.77%)

Hester Biosciences Limited is an India-based animal healthcare company. The Company is primarily engaged in the production and distribution of vaccines and health products. It is also involv... Read More

Corporate Actions

24 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Jan , 2023

12:00 AM

Results

View Details

22 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 Oct , 2022

12:00 AM

Results

View Details

29 Jul , 2022

12:00 AM

AGM

Announcement date: 29 Jul , 2022

View Details

20 May , 2022

12:00 AM

Dividend

Dividend amount: 10
Announcement date: 20 May , 2022

View Details

02 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Aug , 2022

12:00 AM

Results

View Details

12 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Apr , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Jul , 2022

12:00 AM

BookCloser

View Details

Hester Biosciences Ltd News and Update

Mamaearth puts IPO plan on hold: Reports

27 March, 2023 |
4:08 PM

The valuation of the company was estimated to be up to $3 billion.

Adani Power sells Support Properties Private Ltd to AdaniConnex

IIFL News Service |
24 March, 2023 |
4:03 PM

Power Grid Corporation acquires Khavda II-C Transmission Ltd

23 March, 2023 |
4:02 PM

Hindustan Zinc's dividend payments may ease Vedanta's debt repayment challe...

IIFL News Service |
23 March, 2023 |
4:02 PM

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
No Record Found

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Hester Biosciences Ltd

Bhupendra V Gandhi
Chairman (Non-Executive)

Rajiv D Gandhi
Managing Director & CEO

Sanjiv D Gandhi
Non-Exec & Non-Independent Dir

Ravin Gandhi
Non-Exec & Non-Independent Dir

Naman Patel
Non-Exec. & Independent Dir.

Amit Shukla
Non-Exec. & Independent Dir.

Vinod Mali
Company Sec. & Compli. Officer

Nina Gandhi
Alternate Director

Sandhya Patel
Non-Exec. & Independent Dir.

Ashok Bhadakal
Non-Exec. & Independent Dir.

Priya Gandhi
Whole Time Director

Ameet Desai
Independent Director

Summary

Incorporated as a private limited company in Apr.87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.93.HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium.The companys own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation.During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun.The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry... Read More

Reports by Hester Biosciences Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Hester Biosciences Ltd
Investor PresentationConference Call TranscriptConference Call Audio

CALLS						PUTS
Total OI	Chg in Ol	Chg % Ol	LTP	Chg %	Strike Price	Chg %	LTP	Chg % OI	Chg in Ol	Total OI

Hester Biosciences Ltd

₹ 1,567.20 (-4.06%)

Expiry Date:

HESTERBIO - 27-04-2023

Stock View

HOLD

1,830 (16.77%)

KEY RATIOS

Corporate Actions

SHAREHOLDING SNAPSHOT 31 March , 2023 | 07:58 AM

Knowledge Center

Hester Biosciences Ltd News and Update

FINANCIALS

Select Period:

QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

PEER COMPARISON

MORE ABOUT Hester Biosciences Ltd

Bhupendra V Gandhi

Rajiv D Gandhi

Sanjiv D Gandhi

Ravin Gandhi

Naman Patel

Amit Shukla

Vinod Mali

Nina Gandhi

Sandhya Patel

Ashok Bhadakal

Priya Gandhi

Ameet Desai

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

SHAREHOLDING SNAPSHOT
31 March , 2023 | 07:58 AM